EPIGENIX FOUNDATION (EIN 810929302) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

PAUL RAYBOULD

Phone

3104829311

Tax Period

2023-01-01 to 2023-12-31

EPIGENIX FOUNDATION, founded in 2015, is a small nonprofit in the Science & Technology sector that reported $108K in total revenue in fiscal year 2023. Revenue fell 76% from the prior year — a significant decline worth monitoring. Expenses of $126K exceeded revenue, resulting in a 17% operating deficit.

Mission

EPIGENIX FOUNDATION WAS FOUNDED IN LATE 2015 WITH A MISSION TO UNDERSTAND THE EPIGENETIC IMPACT OF METABOLIC INTERVENTIONS OF HUMAN DISEASE AND PERFORMANCE. THE TEAM IS DEDICATED TO STUDYING HOW NUTRITION CAN DETERMINE THE WAY GENETIC PREDISPOSITIONS ARE EXPRESSED AND CAN BE ALTERED THROUGH THE CHOICES HUMANS MAKE. CURRENTLY FOCUSED ON VALIDATING THE EFFICACY OF THE KETOGENIC DIET AND ITS APPLICATION IN REVERSING CANCER AND EXTENDING LONGEVITY. GIVEN THAT EARLY CANCER DETECTION AND INTERVENTION OFFER THE GREATEST LANDSCAPE OF CHOICE IN REVERSING CANCER UTILIZING LOW SIDE EFFECT, NUTRITION BASED THERAPIES, EPIGENIX FOCUSES ITS RESOURCES TO THIS PURPOSE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $108,281

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $108,281

Expense Breakdown

Grants Paid $0

Salaries & Benefits $35,439

Fundraising Expenses $0

Program Expenses $74,058

Other Expenses $90,906

TOTAL EXPENSES $126,345

Year-over-Year Comparison

	2023	2022	Change
Revenue	$108,281	$450,400	-0.8%
Expenses	$126,345	$697,879	-0.8%
Net Income	$-18,064	$-247,479	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$29,750

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PAUL RAYBOULD	PRESIDENT / CEO / BOARD CHAIRMAN	40.00	Officer	$29,750	$0	$29,750

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$108,281	$126,345	$101,644	$-18,064
2020	$1,120,455	$563,377	$681,158	$557,078
2019	$589,777	$561,202	$117,469	$28,575
2018	$778,894	$866,382	$88,903	$-87,488

EPIGENIX FOUNDATION